As an example, the successful performance of HER2 CAR NK cells in primary and immortalized cell types has been validated by marked and selective anti-tumor activity against cancers like rhabdomyosarcoma, in vitro and in vivo [51,125]. This evidence concerns the gene ERBB2 and cancer.